| Quantitative proteome-wide O-glycoproteomics analysis with FragPipe DA Polasky, L Lu, F Yu, K Li, MR Shortreed, LM Smith, AI Nesvizhskii Analytical and Bioanalytical Chemistry, 1-10, 2024 | | 2024 |
| Silyl Ether Enables High Coverage Chemoproteomic Interaction Site Mapping S Takechi, C Ngo, N Burton, M Villanueva, L Boatner, F Yu, P Kim, ... | | 2024 |
| High-throughput mass spectrometry maps the sepsis plasma proteome and differences in patient response Y Mi, KL Burnham, PD Charles, R Heilig, I Vendrell, J Whalley, ... Science Translational Medicine 16 (750), eadh0185, 2024 | | 2024 |
| LONP1 regulation of mitochondrial protein folding provides insight into beta cell failure in type 2 diabetes J Li, J Zhu, Y Deng, EC Reck, EM Walker, V Sidarala, DL Hubers, ... bioRxiv, 2024 | | 2024 |
| An MSstats workflow for detecting differentially abundant proteins in large-scale data-independent acquisition mass spectrometry experiments with FragPipe processing D Kohler, M Staniak, F Yu, AI Nesvizhskii, O Vitek Nature Protocols, 1-24, 2024 | | 2024 |
| Author Correction: Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer L Xiao, A Parolia, Y Qiao, P Bawa, S Eyunni, R Mannan, SE Carson, ... Nature, 1-1, 2024 | | 2024 |
| Integrated stress response plasticity governs normal cell adaptation to chronic stress via the PP2A-TFE3-ATF4 pathway RA Avelar, R Gupta, G Carvette, F da Veiga Leprevost, J Colina, J Teitel, ... Research Square, 2024 | | 2024 |
| Genome instability in renal tumors H Cho, GX Li, R Mannan, N Hosseini, Y Hsiao, Y Zhang, A Dagar, ... Cancer Research 84 (6_Supplement), 5217-5217, 2024 | | 2024 |
| Proteogenomic and metabolomic characterization of acute myeloid leukemia A Chu, Y Hsiao, Y Deng, C Wang, J Kyle, Y Dou, JC Pino, C Posso, ... Cancer Research 84 (6_Supplement), 7354-7354, 2024 | | 2024 |
| A proteogenomic study of high-grade glioma among adolescents and young adults N Tignor, MP Koptyra, S Chowdhury, W Ma, JL Rokita, M Gritsenko, ... Cancer Research 84 (6_Supplement), 3955-3955, 2024 | | 2024 |
| Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides HJ Ferreira, BJ Stevenson, HS Pak, F Yu, J Almeida Oliveira, F Huber, ... Nature Communications 15 (1), 2357, 2024 | 1 | 2024 |
| Integrated proteogenomic characterization of glioblastoma evolution KH Kim, S Migliozzi, H Koo, JH Hong, SM Park, S Kim, HJ Kwon, S Ha, ... Cancer Cell 42 (3), 358-377. e8, 2024 | 4 | 2024 |
| Analysis and visualization of quantitative proteomics data using FragPipe-Analyst Y Hsiao, H Zhang, GX Li, Y Deng, F Yu, HV Kahrood, JR Steele, ... bioRxiv, 2024 | 4 | 2024 |
| Proteome-scale tissue mapping using mass spectrometry based on label-free and multiplexed workflows Y Kwon, J Woo, F Yu, SM Williams, LM Markillie, RJ Moore, ES Nakayasu, ... bioRxiv, 2024 | | 2024 |
| Abstract P27: Proteogenomic and metabolomic analysis of acute myeloid leukemia reveals molecular and functional underpinnings of cellular and clinical phenotypes SC Alec Chu, Y Hsiao, Y Deng, C Wang, J Kyle, Y Dou, J Pino, C Posso, ... Blood Cancer Discovery 5 (2_Supplement), P27-P27, 2024 | | 2024 |
| Pan-cancer proteogenomics characterization of tumor immunity F Petralia, W Ma, TM Yaron, FP Caruso, N Tignor, JM Wang, ... Cell 187 (5), 1255-1277. e27, 2024 | 5 | 2024 |
| Proteogenomic analysis of chemo-refractory high-grade serous ovarian cancer S Chowdhury, JJ Kennedy, RG Ivey, OD Murillo, N Hosseini, X Song, ... Cell 187 (4), 1016, 2024 | | 2024 |
| Abstract A034: Development of a novel class of genomic biomarkers through mathematical modeling of cancer genome contiguity N Hosseini, R Mannan, A Nesvizhskii, S Dhanasekaran, M Cieslik Cancer Research 84 (1_Supplement), A034-A034, 2024 | | 2024 |
| Koina: Democratizing machine learning for proteomics research L Lautenbacher, K Yang, T Kockmann, C Panse, M Chambers, E Kahl, ... bioRxiv, 2024.06. 01.596953, 2024 | | 2024 |
| diaTracer enables spectrum-centric analysis of diaPASEF proteomics data K Li, GC Teo, KL Yang, F Yu, AI Nesvizhskii bioRxiv, 2024.05. 25.595875, 2024 | | 2024 |
Aebersold RETH Zurich在 imsb.biol.ethz.ch 的电子邮件经过验证
